GHK-Cu (the Glow Peptide)
in St. George, Utah

GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine bound to copper). It's been studied since the 1970s for its role in tissue regeneration. GHK-Cu signals skin and hair stem cells to activate, supports collagen and elastin production, accelerates wound healing, and has anti-inflammatory and antioxidant effects. It's the same peptide found in many high-end topical skincare products — but injectable delivery produces systemic effects topical formulas can't reach.

Studied benefits include: stimulation of collagen and elastin in skin (improves fine lines, firmness, and tone), support for hair follicle health and hair regrowth, faster wound and tissue healing, anti-inflammatory effects, and antioxidant activity that protects against oxidative skin damage. Most patients use it as part of a comprehensive aesthetic plan rather than in isolation — it pairs especially well with microneedling and laser treatments.

GHK-Cu can be administered as subcutaneous injection (the most common form for systemic effects), as an IV infusion in some protocols, or topically (less effective than injection). At Aera, we typically use subcutaneous injection 2–3 times weekly for 4–8 week cycles, sometimes paired with microneedling or laser sessions where the peptide is also applied topically immediately after to penetrate the freshly-created micro-channels.

At Aera Medical Aesthetics, GHK-Cu protocols typically run $400–$650 for a 4–8 week cycle including the peptide, injection supplies, and follow-up. When combined with microneedling or laser treatments, package pricing is available. Call (435) 319-4064 for a personalized quote.

GHK-Cu has an excellent safety profile based on decades of research. The naturally-occurring form is identical to peptides circulating in healthy human plasma. Side effects are typically limited to injection-site reactions (mild redness, occasional bruising). Patients with copper allergies, Wilson's disease (copper metabolism disorder), or active cancer should avoid it. As with all peptides, sourcing from licensed compounding pharmacies (not gray-market) is essential.

Clinical research supports GHK-Cu's role in hair follicle stimulation, particularly for early-stage androgenetic alopecia. It signals hair follicle stem cells, supports follicle dermal papilla cells, and improves the local micro-environment around follicles. Results are typically modest-to-moderate after 8–12 weeks of consistent use. It's often layered with other proven treatments (PRP, oral or topical minoxidil, finasteride for men) rather than used alone.

Skin improvements from GHK-Cu are gradual: most patients notice initial brightening and finer texture at 4–6 weeks, with continued improvement over 8–12 weeks as collagen and elastin production builds. The effect compounds when paired with in-office treatments (microneedling, laser) that create channels for additional topical absorption.

Topical copper peptide products (like NIOD CAIS, Skin Better Inter Fuse) deliver smaller amounts to the skin surface — useful for daily maintenance but limited in penetration. Injectable GHK-Cu reaches systemic circulation and produces deeper biological effects: hair follicle activation, deeper dermal collagen, and faster wound healing. The two are complementary — many patients use both.